Science Explorer Back to mapMap
Discussion
Researcher · Vertex Pharmaceuticals (United States) · United States

Neil Ahluwalia

Neil Ahluwalia publishes mostly in Pulmonary and Respiratory Medicine, Emergency Medical Services and Physiology, on topics such as Cystic Fibrosis Research Advances, Pediatric health and respiratory diseases and Neonatal Respiratory Health Research.

ORCID 0000-0001-6262-401X OpenAlex
World rank
#188,989
of 7,710,434 ranked researchers
Rank in United States
#70,343
of 1,627,098
Works
59
Citations
4.4k
Citations per work
74.9
h-index
26
i10-index 32Top 12% in Pulmonary and Respiratory Medicine
Neil Ahluwalia

What does Neil Ahluwalia research?

Neil Ahluwalia's work is mostly in Medicine (52%), Health Professions (11%), Immunology and Microbiology (3%).

Health Sciences: 37 works · 63.0% of their workMedicine: 31 works · 52.0% of their workPulmonary and Respiratory Medicine: 25 works · 41.8% of their workPhysiology: 4 works · 6.8% of their workSurgery: 2 works · 3.4% of their workHealth Professions: 6 works · 11.0% of their workEmergency Medical Services: 6 works · 11.0% of their workEverything else: 18 works · 30.2% of their workLife Sciences: 2 works · 3.4% of their workImmunology and Microbiology: 2 works · 3.4% of their workImmunology: 2 works · 3.4% of their workSocial Sciences: 2 works · 3.4% of their workSocial Sciences: 2 works · 3.4% of their workSociology and Political Science: 2 works · 3.4% of their workTHEIR WORKNeil Ahluwalia59works
Life Sciences3%Health Sciences63%Social Sciences3%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine3152.0%
    2. Health Professions611.0%
  2. Everything else1830.2%
    1. Immunology and Microbiology23.4%
    1. Social Sciences23.4%
  1. 1Pulmonary and Respiratory Medicine42% of their works
  2. 2Emergency Medical Services11% of their works
  3. 3Physiology7% of their works
  4. 4Immunology3% of their works
  5. 5Surgery3% of their works
  6. 6Sociology and Political Science3% of their works

Research topics

Which keywords describe Neil Ahluwalia's research?

The keywords of their largest research topics: CFTR, Cystic Fibrosis, Child Care, Infection Control Measures, Bronchopulmonary Dysplasia, Preterm Infants, Allergic Diseases and Asthma.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 16 words, with their numbers
  1. CFTR361 topic
  2. Cystic Fibrosis361 topic
  3. Child Care141 topic
  4. Infection Control Measures141 topic
  5. Bronchopulmonary Dysplasia111 topic
  6. Preterm Infants111 topic
  7. Allergic Diseases81 topic
  8. Asthma81 topic
  9. Consensus Building51 topic
  10. Delphi Method51 topic
  11. Airway Stenosis31 topic
  12. Aneurysm Screening31 topic
  13. Endovascular Repair31 topic
  14. Fibrosis31 topic
  15. Idiopathic Pulmonary Fibrosis31 topic
  16. Tracheostomy31 topic

Where does Neil Ahluwalia work?

Neil Ahluwalia's main affiliation in the publication record is Vertex Pharmaceuticals (United States), United States.

How many publications and citations does Neil Ahluwalia have?

OpenAlex counts 59 works and 4,421 citations for Neil Ahluwalia, an h-index of 26, ranking #188,989 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Neil Ahluwalia. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.